200,000 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by Kintayl Capital LP

Kintayl Capital LP bought a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 200,000 shares of the pharmacy operator's stock, valued at approximately $2,234,000. Walgreens Boots Alliance comprises approximately 1.6% of Kintayl Capital LP's investment portfolio, making the stock its 23rd biggest holding.

Several other hedge funds have also made changes to their positions in the stock. Proficio Capital Partners LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth $312,000. Raymond James Financial Inc. acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $9,685,000. AlphaQuest LLC grew its position in Walgreens Boots Alliance by 62.8% during the fourth quarter. AlphaQuest LLC now owns 17,095 shares of the pharmacy operator's stock valued at $159,000 after purchasing an additional 6,596 shares in the last quarter. Independent Advisor Alliance increased its stake in Walgreens Boots Alliance by 16.6% in the 4th quarter. Independent Advisor Alliance now owns 38,828 shares of the pharmacy operator's stock valued at $362,000 after buying an additional 5,518 shares during the period. Finally, Sequoia Financial Advisors LLC lifted its position in Walgreens Boots Alliance by 61.1% in the 4th quarter. Sequoia Financial Advisors LLC now owns 40,629 shares of the pharmacy operator's stock worth $379,000 after buying an additional 15,414 shares in the last quarter. Institutional investors own 58.59% of the company's stock.

Wall Street Analysts Forecast Growth

WBA has been the topic of a number of analyst reports. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Wall Street Zen started coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They issued a "hold" rating for the company. Finally, Morgan Stanley restated an "underweight" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Stock Down 0.0%

Shares of NASDAQ:WBA traded down $0.01 during midday trading on Thursday, reaching $11.52. The company had a trading volume of 2,853,495 shares, compared to its average volume of 19,123,074. The business's 50 day moving average price is $11.35 and its 200 day moving average price is $10.99. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $13.25. The company has a quick ratio of 0.32, a current ratio of 0.60 and a debt-to-equity ratio of 0.96. The stock has a market cap of $9.97 billion, a PE ratio of -1.58, a P/E/G ratio of 1.35 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. Walgreens Boots Alliance's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.63 EPS. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, Chairman Stefano Pessina bought 832,258 shares of Walgreens Boots Alliance stock in a transaction that occurred on Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the acquisition, the chairman owned 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 17.50% of the stock is owned by insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.